For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Tenaya Therapeutics Inc (NASDAQ: TNYA) closed at $1.9 in the last session, down -5.00% from day before closing price of $2.0. In other words, the price has decreased by -$5.00 from its previous closing price. On the day, 6.7 million shares were traded. TNYA stock price reached its highest trading level at $2.04 during the session, while it also had its lowest trading level at $1.8.
Ratios:
We take a closer look at TNYA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.00 and its Current Ratio is at 6.00. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.09.
On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 18 ’25 when Higa Tomohiro sold 2,962 shares for $1.25 per share. The transaction valued at 3,711 led to the insider holds 95,338 shares of the business.
Tingley Whittemore sold 5,053 shares of TNYA for $6,331 on Aug 18 ’25. The Chief Medical Officer now owns 172,803 shares after completing the transaction at $1.25 per share. On Aug 18 ’25, another insider, Ali Faraz, who serves as the Chief Executive Officer of the company, sold 14,533 shares for $1.25 each. As a result, the insider received 18,210 and left with 302,792 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 309654592 and an Enterprise Value of 250197600.
Stock Price History:
The Beta on a monthly basis for TNYA is 3.12, which has changed by -0.069767416 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, TNYA has reached a high of $4.01, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is 42.85%, while the 200-Day Moving Average is calculated to be 111.33%.
Shares Statistics:
According to the various share statistics, TNYA traded on average about 3.73M shares per day over the past 3-months and 5397230 shares per day over the past 10 days. A total of 162.98M shares are outstanding, with a floating share count of 138.17M. Insiders hold about 15.22% of the company’s shares, while institutions hold 18.02% stake in the company. Shares short for TNYA as of 1759190400 were 14980954 with a Short Ratio of 4.01, compared to 1756425600 on 13937149. Therefore, it implies a Short% of Shares Outstanding of 14980954 and a Short% of Float of 25.240000000000002.
Earnings Estimates
Tenaya Therapeutics Inc (TNYA) is presently subject to a detailed evaluation by 8.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.07 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.58 and -$0.81 for the fiscal current year, implying an average EPS of -$0.69. EPS for the following year is -$0.6, with 6.0 analysts recommending between -$0.51 and -$0.73.
